SCHEMBL270650

SCHEMBL270650

CCCCCCN(C=O)CCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 3/20 0.52
ADH1A P07327 3/20 0.52
ADH4 P08319 3/20 0.52
DNM1 Q05193 4/20 0.48
TSHR P16473 3/20 0.46
ADH1B P00325 2/20 0.42
ADH7 P40394 2/20 0.42
EPHX1 P07099 1/20 0.42
THRB P10828 1/20 0.42
FAAH O00519 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
S1PR2 O95136 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3954905 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL7774990 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL276871 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL5479572 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL277587 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL276848 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL3962903 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL55195 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL5175186 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL95389 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597873-B2 Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency FLOTEK CHEMISTRY, LLC (US) 2023-03-07 US disclosed
US-11254856-B2 Methods and compositions for use in oil and/or gas wells FLOTEK CHEMISTRY, LLC (US) 2022-02-22 US disclosed
US-20210371730-A1 WELL TREATMENT COMPOSITIONS AND METHODS COMPRISING CERTAIN MICROEMULSIONS AND CERTAIN CLAY CONTROL ADDITIVES EXHIBITING SYNERGISTIC EFFECT OF ENHANCING CLAY SWELLING PROTECTION AND PERSISTENCY FLOTEK CHEMISTRY, LLC (US) 2021-12-02 US disclosed
US-11180690-B2 Diluted microemulsions with low surface tensions FLOTEK CHEMISTRY, LLC (US) 2021-11-23 US disclosed
US-20210340435-A1 METHODS AND COMPOSITIONS FOR STIMULATING THE PRODUCTION OF HYDROCARBONS FROM SUBTERRANEAN FORMATIONS FLOTEK CHEMISTRY, LLC (US) 2021-11-04 US disclosed
US-11053433-B2 Methods and compositions for stimulating the production of hydrocarbons from subterranean formations FLOTEK CHEMISTRY, LLC (US) 2021-07-06 US disclosed
US-20210179924-A1 COMPOSITIONS COMPRISING NON-HALOGENATED SOLVENTS FOR USE IN OIL AND/OR GAS WELLS AND RELATED METHODS FLOTEK CHEMISTRY, LLC (US) 2021-06-17 US disclosed
US-11034879-B2 Methods and compositions for use in oil and/or gas wells FLOTEK CHEMISTRY, LLC (US) 2021-06-15 US disclosed
US-20210108132-A1 WELL TREATMENT COMPOSITIONS AND METHODS COMPRISING CERTAIN MICROEMULSIONS AND CERTAIN CLAY CONTROL ADDITIVES EXHIBITING SYNERGISTIC EFFECT OF ENHANCING CLAY SWELLING PROTECTION AND PERSISTENCY FLOTEK CHEMISTRY, LLC (US) 2021-04-15 US disclosed
US-10934472-B2 Compositions comprising non-halogenated solvents for use in oil and/or gas wells and related methods FLOTEK CHEMISTRY, LLC (US) 2021-03-02 US disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
US-4217111-A REDUCING OCTANE REQUIREMENT CHEVRON RESEARCH COMPANY (US) 1980-08-12 US disclosed